Skip to content

Clinical trials

Observational Tuberculosis, Multidrug-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Multidrug-Resistant Phase: Observational Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20102
20112
20122
20134
20155
20163
20173
20182
20193
20206
20211
20222
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status9
Recruiting3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Foundation for Innovative New Diagnostics, Switzerland5
University Medical Center Groningen3
Centre de Recherche Médicale de Lambaréné2
Korea Otsuka Pharmaceutical Co., Ltd.2
Medecins Sans Frontieres, Netherlands2
National Institute of Allergy and Infectious Diseases (NIAID)2
Research Center Borstel2
University of Cape Town2
Assistance Publique - Hôpitaux de Paris1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Multidrug-Resistant41
Tuberculosis16
Extensively Drug-Resistant Tuberculosis5
Tuberculosis, Pulmonary5
Latent Tuberculosis4
Disease3
HIV Infections1
Mycobacterium Infections1
Sprains and Strains1
Tuberculosis, Extrapulmonary1

Trials

Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.